Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Cancer Cell|February 15, 2011
Monoallelic deletion of NFKBIA in glioblastoma: when less is moreAmanda L Rinkenbaugh, Albert S BaldwinOncotarget|October 13, 2016
IKK/NF-κB signaling contributes to glioblastoma stem cell maintenanceAmanda L Rinkenbaugh, Patricia C Cogswell, Barbara Calamini, et al.Nature Communications|August 19, 2021
Single-cell evaluation reveals shifts in the tumor-immune niches that shape and maintain aggressive lesions in the breastVidya C Sinha, Amanda L Rinkenbaugh, Mingchu Xu, et al.Science Advances|April 3, 2026
Regulation of mitochondrial ROS by C15ORF48 in a basal cell subpopulation contributes to chemotherapy resistance in TNBCYan Jiang, Noor M Abdulkareem, Amanda L Rinkenbaugh, et al.Proceedings of the National Academy of Sciences of the United States of America|April 10, 2026
Resistance to neoadjuvant talazoparib in triple-negative breast cancer by BRN2-induced ATR/STAT3 pathways or SHLD2 subclone expansionNoor M Abdulkareem, Yan Jiang, Yuan Qi, et al.NPJ Breast Cancer|May 27, 2024
Targeting neddylation and sumoylation in chemoresistant triple negative breast cancerReid T Powell, Amanda L Rinkenbaugh, Lei Guo, et al.Cancer Research|August 13, 2025
An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples During Neoadjuvant ChemotherapyAmanda L Rinkenbaugh, Yuan Qi, Shirong Cai, et al.Biorxiv : the Preprint Server for Biology|December 9, 2024
An annotated biobank of triple negative breast cancer patient-derived xenografts featuring treatment-naïve and longitudinal samples throughout neoadjuvant chemotherapyAmanda L Rinkenbaugh, Yuan Qi, Shirong Cai, et al.NPJ Breast Cancer|January 10, 2023
Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancerGloria V Echeverria, Shirong Cai, Yizheng Tu, et al.Pageof 2